Ftlosciencefeed

Imagine sitting through a talk at a medical conference, only to see the same speaker return later in a different headscarf and with a different name tag. That is exactly what an Oxford doctoral student noticed at a pneumonia conference in Copenhagen this May, where one woman appeared to be presenting different studies under different names (

It is truly a modern marvel that a tiny island nation, with little in the way of natural resources, is widely considered a leading figure in trade and commerce. A key driver of this success has been our investment in world-class seaports and airports.

With this in mind, we might be forgiven for having our sights set firmly on the surface of Earth, resisting the head...

“New drug cuts risk of death by 60%.” “Patients lived twice as long.” Headlines like these appear every time a big clinical trial reports, but what do the numbers actually mean? To find out, we need to understand a few statistics that show up in almost every trial. These are hazard ratios, Kaplan–Meier curves, median survival and absolute versus relative risk. Throughout this...

On 31 May 2026, thousands of cancer doctors at the world’s biggest oncology conference rose to their feet in the middle of a presentation and applauded for nearly a minute! The reason was a once-daily pill which roughly doubled survival in advanced pancreatic cancer, one of the deadliest cancers there is. Less than three months later, the FDA gave Rasonque (daraxonras...

It’s that time of the year again as we walk you through the FDA new drug approvals of the past twelve months. We break down the approvals by the numbers and highlight each small molecule and biologic therapy approved. We provide a short description of how they work, their competitors and pivotal clinical trials for all 46 new medicines entering the market in 2025.